This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ramani, A. Articles by Nayak, M.N. Search for Related Content PubMed PubMed Citation Articles by Ramani, A. Articles by Nayak, M.N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Social Bookmarking                   What's this?

Hemorheologic Approach in the Treatment of Diabetic Foot Ulcers

G.N. Kundaje

M.N. Nayak

Pentoxifylline, a new trisubstituted methyxanthine derivative, is the most well known of a new group of hemorheologic agents. It has been shown to im prove hemorheologic abnormalities associated with diabetes and atherosclero sis. The authors examined the role of pentoxifylline in the treatment of diabetic foot ulcers. Forty diabetic patients with foot ulcerations were included in the study, 20 of whom received conventional therapy and 20 received pentoxifylline (400 mg three times a day) in addition. Healing of ulcers after eight weeks of treatment was significantly higher in those on pentoxifylline, and the patients needed less multilating surgery. Administration of pentoxifylline in addition to conventional therapy was significantly superior in the management of diabetic foot ulcers.

Angiology, Vol. 44, No. 8, 623-626 (1993)
DOI: 10.1177/000331979304400805


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?